Clinical trial reports

Which CROs Support the Most Melanoma Phase II & III Trials in Europe?
How Long Are Phase I Infectious Disease CTIS Reviews and What Drives Delay?
Eligibility Patterns in Breast Cancer Phase III Trials
Which Endpoints Are Measured Most Often in European Infectious Disease Phase II and Phase III Trials?
Which Endpoints Are Measured Most Often in European Multiple Myeloma Phase II & III Trials?
Which Endpoints Are Most Often Measured in European Chronic Kidney Disease and Kidney Failure Phase II & III Trials?
Which CROs Support Orphan Drug Phase III Trials in Europe, and When Are They Needed Most?
Which European sites lead RNA Phase III trial activity in 2024–2026?
Which CROs Are Most Active in European Ophthalmology Phase 2 & 3 Trials?
How are 2025 Phase III lung cancer trials being designed in Europe?
Where Are CROs Most Active in European Vaccine Phase 1 - 3 Trials?
EU Phase II Neurology CTIS Timelines and Contributing Factors